Design considerations for AIDS trials.

Statisticians and clinicians involved in the design and conduct of trials of new treatments for the acquired immunodeficiency syndrome (AIDS) have realized that some traditional approaches to the c...

[1]  D J Schaid,et al.  A design for phase II testing of anticancer agents within a phase III clinical trial. , 1988, Controlled clinical trials.

[2]  A. Moss.  Predicting who will progress to AIDS. , 1988, BMJ.

[3]  M. Feinberg,et al.  HIV revealed: toward a natural history of the infection. , 1989, The New England journal of medicine.

[4]  D P Byar,et al.  Assessing apparent treatment--covariate interactions in randomized clinical trials. , 1985, Statistics in medicine.

[5]  J. Godbold,et al.  Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: reappraisal of risk and predictive factors. , 1989, The American journal of medicine.

[6]  P F Thall,et al.  A two-stage design for choosing among several experimental treatments and a control in clinical trials. , 1989, Biometrics.

[7]  S. Green,et al.  Issues in the design of drug trials for AIDS. , 1990, Controlled clinical trials.

[8]  S W Lagakos,et al.  Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection , 1990 .

[9]  H. Mitsuya,et al.  In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine. , 1989, Science.

[10]  A. Palestine,et al.  Clinical aspects of cytomegalovirus retinitis. , 1988, Reviews of infectious diseases.

[11]  D. Ho,et al.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.

[12]  M A Fischl,et al.  The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.

[13]  A. Collier,et al.  Plasma viremia in human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[14]  Richard Simon,et al.  Two-stage selection and testing designs for comparative clinical trials , 1988 .

[15]  G. Rutherford,et al.  The natural history of human immunodeficiency virus infection. , 1988, The Journal of infectious diseases.

[16]  R. Redfield,et al.  Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy. , 1989, The New England journal of medicine.

[17]  D P Byar,et al.  Using observational data from registries to compare treatments: the fallacy of omnimetrics. , 1984, Statistics in medicine.

[18]  M. Jacobson,et al.  Treatment of cytomegalovirus retinitis in patients with AIDS. , 1988, Reviews of infectious diseases.